ASI Entertainment, Inc. has been advised that ASIQ Limited, the licensee for the SafeCell system, announced that ASiQ Limited Australia launched the world’s most expensive mobile phone App. The mobile phone app is available for $12,500 and can be used to make in-flight calls.The full text of the announcement is available online.
As per the license agreement, ASiQ Limited receives 10% royalties on all gross revenue generated by SafeCell.
ASI owns the intellectual property of SafeCell. SafeCell is a new generation software application that converts a normal mobile phone into a wireless communicator. SafeCell was developed to substantially reduce the cost of SMS, MMS, Chat, and Email for the regional and international airline traveller.
SafeCell connects via Bluetooth, so it operates with any modern mobile phone, including the new generation mobile phones that already have wireless interface. SafeCell delivers its services via the internet and is designed for operation in-flight and on the ground.
Recently, ASI Entertainment was in news when the company announced the completion of the SafeCell Aviation Valuation. The company also announced that it was in receipt of the independent expert’s report.Valutech Pty Ltd, completed the independent valuation report on behalf of IC Consulting Services, LLC differentiated SafeCell from alternate pico cell systems and confirmed the commercial viability of ASIE's patented SafeCell aviation communication technology.
The SafeCell aviation application has been licensed to ASiQ Ltd.To create the independent report three separate valuation methodologies needed to taken into account. These methodologies are based on three year projections totaling 1,000 aircraft, or 5 percent take-up of the overall airliner market, plus 10 percent p.a. incremental growth in years four and five.
Sujata Garud is a TMCnet freelancer with three years of writing/editing experience and two years of market research experience. As an editor she has covered the IT, electronics, banking, pharma, construction, mining and healthcare industries. To see more of her articles, please visit her columnist page.
Edited by Erin Monda